Detailed Gabapentin dosage information for adults and children. Includes dosages for Restless Legs Syndrome, Epilepsy and Postherpetic Neuralgia; plus renal, liver and dialysis adjustments. Gabapentin was very well tolerated, with only a few minor adverse effects. Conclusions: Gabapentin has a similar body of evidence as other pharmacotherapeutic agents used to treat hiccups. We report a patient with a history of Guillain-Barré syndrome and metastatic gastric neoplasm who presented with intractable hiccup that successfully responded to treatment with gabapentin plus baclofen. A search of MEDLINE (1966-March 2013) using the MeSH search terms gabapentin, hiccups, and hiccups/drug therapy was performed. Additional databases searched included Web of Science (1945-March 2013) and International Pharmaceutical Abstracts (1970-March 2013) using the text words gabapentin and hiccups. Bibliographies of relevant articles were reviewed for additional citations. He received metoclopramide for two days without improvement. Based on his medical history and a probable neurogenic etiology, gabapentin was recommended for his hiccups. Symptoms improved within several hours, with complete resolution after a dose titration to 200 mg twice daily on the second day of gabapentin treatment. Hiccups, medically known as singultus, are sudden, involuntary contractions of the diaphragm muscle. While most hiccups are self-limiting, persistent or intractable hiccups may require medical intervention. Below is a structured approach to managing hiccups using specific medications. It is unusual for persons to seek care for hiccups unless the episode is particularly prolonged. Prolonged hiccups, however, can be debilitating and may be a sign of serious underlying disease. Explore the causes, evaluation, and treatment of hiccups, a common condition characterized by involuntary diaphragm contractions and abrupt glottis closure. As hiccups, with most the mechanism therapeutic interventions by which gabapentin in the management affects hiccups of days and second dose gabapentin was stopped. gabapentin to 400 mg/day hiccups abated another 3 The results of the study allow suggesting gabapentin at least as a promising drug in the treatment of severe chronic hiccups in advanced cancer patients. Hiccups may appear to be a common normal phenomenon that does not warrant treatment in the general population. However, severe and persistent hiccups can become annoying and distressing and may decrease the quality of life, especially in cancer Gabapentin is useful in the management of persistent hiccups in malignancy and has the advantage of low dosing, gradual titration of dosage, fewer drug interactions, and systemic effects. For people with hiccups any duration: Advise them to avoid any identified trigger factors (where possible). Suggest the use of self-help remedies during a bout of hiccups, such as: Breath holding. The Valsalva manoeuvre (a forced expiration against a closed glottis). Breathing into a paper bag. Pulling on the tongue. Sneezing. Swallowing a teaspoon of granulated sugar. Tasting vinegar or Haloperidol – a useful alternative to chlorpromazine; give a 2-5 mg (SubQ/PO) loading dose followed by 1-4 mg PO TID. Anti-Convulsants: Gabapentin – at doses of 300-400 TID has been described as effective in multiple case reports. Its dual role as an analgesic may make it an especially attractive therapeutic agent. Gabapentin can be useful alone or as add-on therapy. Reducing the frequency of recurrent or persistent hiccups is important, as it will improve overall quality of life. BOTTOM LINE Hiccups are a common human experience, but can create a great deal of physical and emotional discomfort in end-stage disease. Gabapentin has a similar body of evidence as other pharmacotherapeutic agents used to treat hiccups. Gabapentin is well tolerated and should be considered as a second-line agent in selected patients. Various agents have been reported to cure hiccups. Gabapentin, baclofen, and metoclopramide appear to show promise for persistent hiccups alone, in combination with other drugs, including proton-pump inhibitors, or as conjoined therapy. [2, 22] In a systematic review of pharmacologic therapy for persistent/intractable hiccups in 341 patients in 15 studies, Steger et al noted that treatment of Porzio et al. [12] in their retrospective study evaluated gabapentin’s efficacy in patients with advanced cancer having severe chronic hiccups and concluded that gabapentin can be used as a next line therapy to chlorpromazine. Conclusion Baclofen, gabapentin, and metoclopramide were the only agents that were studied in a prospective manner, while only baclofen and metoclopramide were studied in randomized controlled trials. No specific recommendations can be made for treating intractable and persistent hiccups with the evidence currently available in the literature. e presence of hiccups was routinely assessed. Patients with severe chronic hiccups were treated with gabapentin (300 mg t.i.d.). Doses of gabapentin were titrated based on the response to treatment. Gabapentin-related adverse effects were recorded. Results: Thirty-seven (3.9%) of 944 in-hospital patients and 6 (4.5%) of 134 patients observed at home presented severe chronic hiccups. We
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |